SC 13G/A: AN2 Therapeutics, Inc.
Ticker: ANTX · Form: SC 13G/A · Filed: Feb 14, 2024 · CIK: 1880438
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by AN2 Therapeutics, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,164 words · 5 min read · ~4 pages · Grade level 7.3 · Accepted 2024-02-14 14:29:58
Key Financial Figures
- $0.00001 — INC. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class of
Filing Documents
- an2schedule13gaexitfiling2.htm (SC 13G/A) — 49KB
- 0000078003-24-000031.txt ( ) — 51KB
OWNERSHIP
ITEM 4. OWNERSHIP. The information requested in this item is incorporated herein by reference to the cover pages of Pfizer and Anacor to this Schedule 13G.
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following X .
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable.
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. Page 5 of 7 CUSIP No. 0037326105
NOTICE OF DISSOLUTION OF GROUP
ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable.
CERTIFICATION
ITEM 10. CERTIFICATION Not applicable. Page 6 of 7 CUSIP No. 0037326105 Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated February 14, 2024 PFIZER INC. By s Susan Grant Name Susan Grant Title Assistant Secretary ANACOR PHARMACEUTICALS, LLC By s Susan Grant Name Susan Grant Title Secretary Page 7 of 7